Expression and Role of HMGA1 in Renal Cell Carcinoma

被引:34
作者
Takaha, Natsuki [1 ,2 ]
Sowa, Yoshihiro [3 ]
Takeuchi, Ichiro
Hongo, Fumiya
Kawauchi, Akihiro
Miki, Tsuneharu
机构
[1] Kyoto Prefectural Univ Med, Dept Translat Canc Drug Dev, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, Kyoto 6028566, Japan
[3] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto 6028566, Japan
关键词
apoptosis; carcinoma; renal cell; HMGA1; protein; molecular targeted therapy; anoikis; GROUP PROTEIN I(Y); IN-SITU HYBRIDIZATION; PROSTATE-CANCER CELLS; PANCREATIC ADENOCARCINOMA; ANOIKIS RESISTANCE; DIAGNOSTIC MARKER; GENE-EXPRESSION; TRANSGENIC MICE; GROWTH; METASTASIS;
D O I
10.1016/j.juro.2012.01.069
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Although molecular targeted therapy has improved the clinical outcome of metastatic renal cell carcinoma, a complete response is rare and there are various side effects. Identifying novel target molecules is necessary to improve the clinical outcome of metastatic renal cell carcinoma. HMGA1 is over expressed in many types of cancer and it is associated with metastatic potential. It is expressed at low levels or not expressed in normal tissue. We examined HMGA1 expression and function in human renal cell carcinoma. Materials and Methods: HMGA1 expression in surgical specimen from patients with renal cell carcinoma was examined by immunoblot. HMGA1 expression in 6 human renal cell carcinoma cell lines was examined by immunoblot and immunofluorescence. The molecular effects of siRNA mediated knockdown of HMGA1 were examined in ACHN and Caki-1 cells. Results: Immunoblot using surgical specimen showed that HMGA1 was not expressed in normal kidney tissue but it was expressed in tumor tissue in 1 of 30 nonmetastatic (3%) and 6 of 18 metastatic (33%) cases (p = 0.008). Immunoblot and immunofluorescence revealed significant nuclear expression of HMGA1 in ACHN and Caki-1 cells derived from metastatic sites. HMGA1 knockdown remarkably suppressed colony formation and induced significant apoptosis in ACHN and Caki-1 cells. HMGA1 knockdown significantly inhibited invasion and migration in vitro, and induced anoikis associated with P-Akt down-regulation in ACHN cells. Conclusions: HMGA1 is a potential target for novel therapeutic modalities for metastatic renal cell carcinoma.
引用
收藏
页码:2215 / 2222
页数:8
相关论文
共 50 条
[31]   Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis [J].
Saed, Lias ;
Jelen, Agnieszka ;
Mirowski, Marek ;
Salagacka-Kubiak, Aleksandra .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
[32]   Circ_0035483 Functions as a Tumor Promoter in Renal Cell Carcinoma via the miR-31-5p-Mediated HMGA1 Upregulation [J].
Liu, Zheng ;
Wang, Ronghai ;
Zhu, Guangze .
CANCER MANAGEMENT AND RESEARCH, 2021, 13 :693-706
[33]   miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1 [J].
Lin, Yiwei ;
Chen, Hong ;
Hu, Zhenghui ;
Mao, Yeqing ;
Xu, Xianglai ;
Zhu, Yi ;
Xu, Xin ;
Wu, Jian ;
Li, Shiqi ;
Mao, Qiqi ;
Zheng, Xiangyi ;
Xie, Liping .
FEBS LETTERS, 2013, 587 (15) :2467-2473
[34]   HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models1 [J].
Andreozzi, Mariacarla ;
Quintavalle, Cristina ;
Benz, David ;
Quagliata, Luca ;
Matter, Matthias ;
Calabrese, Diego ;
Tosti, Nadia ;
Ruiz, Christian ;
Trapani, Francesca ;
Tornillo, Luigi ;
Fusco, Alfredo ;
Heim, Markus H. ;
Ng, Charlotte K. Y. ;
Pallante, Pierlorenzo ;
Terracciano, Luigi M. ;
Piscuoglio, Salvatore .
NEOPLASIA, 2016, 18 (12) :724-731
[35]   Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis [J].
Di Cello, Francescopaolo ;
Dhara, Surajit ;
Hristov, Alexandra C. ;
Kowalski, Jeanne ;
Elbahloul, Ossama ;
Hillion, Joelle ;
Roy, Sujayita ;
Meijerink, Jules P. P. ;
Winter, Stuart S. ;
Larson, Richard S. ;
Huso, David L. ;
Resar, Linda .
LEUKEMIA & LYMPHOMA, 2013, 54 (08) :1762-1768
[36]   Expression of AKT1 Related with Clinicopathological Parameters in Clear Cell Renal Cell Carcinoma [J].
Choi, Taesoo ;
Yoo, Koo Han ;
Kim, Man S. .
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (10) :4921-4929
[37]   The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development [J].
Sumter, T. F. ;
Xian, L. ;
Huso, T. ;
Koo, M. ;
Chang, Y. -T. ;
Almasri, T. N. ;
Chia, L. ;
Inglis, C. ;
Reid, D. ;
Resar, L. M. S. .
CURRENT MOLECULAR MEDICINE, 2016, 16 (04) :353-393
[38]   Role of AMPK/mTOR-independent autophagy in clear cell renal cell carcinoma [J].
Radovanovic, Milan ;
Vidicevic, Sasenka ;
Tasic, Jelena ;
Tomonjic, Nina ;
Stanojevic, Zeljka ;
Nikic, Predrag ;
Vuksanovic, Aleksandar ;
Dzamic, Zoran ;
Bumbasirevic, Uros ;
Isakovic, Aleksandra ;
Trajkovic, Vladimir .
JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (08) :1386-1393
[39]   Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models [J].
Trapasso, F ;
Sarti, M ;
Cesari, R ;
Yendamuri, S ;
Dumon, KR ;
Aqeilan, RI ;
Pentimalli, F ;
Infante, L ;
Alder, H ;
Abe, N ;
Watanabe, T ;
Viglietto, G ;
Croce, CM ;
Fusco, A .
CANCER GENE THERAPY, 2004, 11 (09) :633-641
[40]   Expression of DLC-1 in Clear Cell Renal Cell Carcinoma: Prognostic Significance for Progression and Metastasis [J].
Zhang, Tao ;
Zheng, Jingcun ;
Liu, Chunfang ;
Lu, Yuan .
UROLOGIA INTERNATIONALIS, 2009, 82 (04) :380-387